Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Growth (Status and Outlook) 2026-2032
The global Isocitrate Dehydrogenase (IDH) Inhibitors market size is predicted to grow from US$ 628 million in 2025 to US$ 1378 million in 2032; it is expected to grow at a CAGR of 12.1% from 2026 to 2032.
Isocitrate Dehydrogenase (IDH) Inhibitors are a class of targeted cancer therapies designed to inhibit the activity of mutated forms of isocitrate dehydrogenase enzymes, particularly IDH1 and IDH2. These enzymes play a crucial role in the citric acid cycle (Krebs cycle), and mutations in these genes can lead to the accumulation of oncometabolites like 2-hydroxyglutarate (2-HG), which contributes to tumorigenesis.
United States market for Isocitrate Dehydrogenase (IDH) Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Isocitrate Dehydrogenase (IDH) Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Isocitrate Dehydrogenase (IDH) Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Isocitrate Dehydrogenase (IDH) Inhibitors players cover Agios Pharmaceuticals, Bristol-Myers Squibb, Idenix Pharmaceuticals, Novartis, Bayer AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Isocitrate Dehydrogenase (IDH) Inhibitors Industry Forecast” looks at past sales and reviews total world Isocitrate Dehydrogenase (IDH) Inhibitors sales in 2025, providing a comprehensive analysis by region and market sector of projected Isocitrate Dehydrogenase (IDH) Inhibitors sales for 2026 through 2032. With Isocitrate Dehydrogenase (IDH) Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Isocitrate Dehydrogenase (IDH) Inhibitors industry.
This Insight Report provides a comprehensive analysis of the global Isocitrate Dehydrogenase (IDH) Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Isocitrate Dehydrogenase (IDH) Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Isocitrate Dehydrogenase (IDH) Inhibitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Isocitrate Dehydrogenase (IDH) Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Isocitrate Dehydrogenase (IDH) Inhibitors.
This report presents a comprehensive overview, market shares, and growth opportunities of Isocitrate Dehydrogenase (IDH) Inhibitors market by product type, application, key players and key regions and countries.
Segmentation by Type:
The report requires updating with new data and is sent in 48 hours after order is placed.
Isocitrate Dehydrogenase (IDH) Inhibitors are a class of targeted cancer therapies designed to inhibit the activity of mutated forms of isocitrate dehydrogenase enzymes, particularly IDH1 and IDH2. These enzymes play a crucial role in the citric acid cycle (Krebs cycle), and mutations in these genes can lead to the accumulation of oncometabolites like 2-hydroxyglutarate (2-HG), which contributes to tumorigenesis.
United States market for Isocitrate Dehydrogenase (IDH) Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Isocitrate Dehydrogenase (IDH) Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Isocitrate Dehydrogenase (IDH) Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Isocitrate Dehydrogenase (IDH) Inhibitors players cover Agios Pharmaceuticals, Bristol-Myers Squibb, Idenix Pharmaceuticals, Novartis, Bayer AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Isocitrate Dehydrogenase (IDH) Inhibitors Industry Forecast” looks at past sales and reviews total world Isocitrate Dehydrogenase (IDH) Inhibitors sales in 2025, providing a comprehensive analysis by region and market sector of projected Isocitrate Dehydrogenase (IDH) Inhibitors sales for 2026 through 2032. With Isocitrate Dehydrogenase (IDH) Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Isocitrate Dehydrogenase (IDH) Inhibitors industry.
This Insight Report provides a comprehensive analysis of the global Isocitrate Dehydrogenase (IDH) Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Isocitrate Dehydrogenase (IDH) Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Isocitrate Dehydrogenase (IDH) Inhibitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Isocitrate Dehydrogenase (IDH) Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Isocitrate Dehydrogenase (IDH) Inhibitors.
This report presents a comprehensive overview, market shares, and growth opportunities of Isocitrate Dehydrogenase (IDH) Inhibitors market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Oral Inhibitors
- Intravenous Inhibitors
- Hospital
- Research Center
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Agios Pharmaceuticals
- Bristol-Myers Squibb
- Idenix Pharmaceuticals
- Novartis
- Bayer AG
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size (2021-2032)
2.1.2 Isocitrate Dehydrogenase (IDH) Inhibitors Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Isocitrate Dehydrogenase (IDH) Inhibitors by Country/Region (2021, 2025 & 2032)
2.2 Isocitrate Dehydrogenase (IDH) Inhibitors Segment by Type
2.2.1 Oral Inhibitors
2.2.2 Intravenous Inhibitors
2.2.3 Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type
2.2.3.1 Isocitrate Dehydrogenase (IDH) Inhibitors Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Type (2021-2026)
2.3 Isocitrate Dehydrogenase (IDH) Inhibitors Segment by Application
2.3.1 Hospital
2.3.2 Research Center
2.3.3 Other
2.3.4 Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application
2.3.4.1 Isocitrate Dehydrogenase (IDH) Inhibitors Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Application (2021-2026)
3 ISOCITRATE DEHYDROGENASE (IDH) INHIBITORS MARKET SIZE BY PLAYER
3.1 Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Player
3.1.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue by Player (2021-2026)
3.1.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Player (2021-2026)
3.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ISOCITRATE DEHYDROGENASE (IDH) INHIBITORS BY REGION
4.1 Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (2021-2026)
4.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Annual Revenue by Country/Region (2021-2026)
4.3 Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth (2021-2026)
4.4 APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth (2021-2026)
4.5 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth (2021-2026)
4.6 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021-2026)
5.2 Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026)
5.3 Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (2021-2026)
6.2 APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026)
6.3 APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021-2026)
7.2 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026)
7.3 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors by Region (2021-2026)
8.2 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026)
8.3 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ISOCITRATE DEHYDROGENASE (IDH) INHIBITORS MARKET FORECAST
10.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Region (2027-2032)
10.1.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Region (2027-2032)
10.1.2 Americas Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.1.3 APAC Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.1.4 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.1.5 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.2 Americas Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Country (2027-2032)
10.2.1 United States Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.2.2 Canada Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.2.3 Mexico Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.2.4 Brazil Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.3 APAC Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Region (2027-2032)
10.3.1 China Isocitrate Dehydrogenase (IDH) Inhibitors Market Forecast
10.3.2 Japan Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.3.3 Korea Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.3.4 Southeast Asia Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.3.5 India Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.3.6 Australia Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.4 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Country (2027-2032)
10.4.1 Germany Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.4.2 France Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.4.3 UK Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.4.4 Italy Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.4.5 Russia Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.5 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Region (2027-2032)
10.5.1 Egypt Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.5.2 South Africa Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.5.3 Israel Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.5.4 Turkey Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.6 Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Type (2027-2032)
10.7 Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
11 KEY PLAYERS ANALYSIS
11.1 Agios Pharmaceuticals
11.1.1 Agios Pharmaceuticals Company Information
11.1.2 Agios Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
11.1.3 Agios Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Agios Pharmaceuticals Main Business Overview
11.1.5 Agios Pharmaceuticals Latest Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Information
11.2.2 Bristol-Myers Squibb Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
11.2.3 Bristol-Myers Squibb Isocitrate Dehydrogenase (IDH) Inhibitors Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bristol-Myers Squibb Main Business Overview
11.2.5 Bristol-Myers Squibb Latest Developments
11.3 Idenix Pharmaceuticals
11.3.1 Idenix Pharmaceuticals Company Information
11.3.2 Idenix Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
11.3.3 Idenix Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Idenix Pharmaceuticals Main Business Overview
11.3.5 Idenix Pharmaceuticals Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
11.4.3 Novartis Isocitrate Dehydrogenase (IDH) Inhibitors Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Bayer AG
11.5.1 Bayer AG Company Information
11.5.2 Bayer AG Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
11.5.3 Bayer AG Isocitrate Dehydrogenase (IDH) Inhibitors Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Bayer AG Main Business Overview
11.5.5 Bayer AG Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size (2021-2032)
2.1.2 Isocitrate Dehydrogenase (IDH) Inhibitors Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Isocitrate Dehydrogenase (IDH) Inhibitors by Country/Region (2021, 2025 & 2032)
2.2 Isocitrate Dehydrogenase (IDH) Inhibitors Segment by Type
2.2.1 Oral Inhibitors
2.2.2 Intravenous Inhibitors
2.2.3 Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type
2.2.3.1 Isocitrate Dehydrogenase (IDH) Inhibitors Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Type (2021-2026)
2.3 Isocitrate Dehydrogenase (IDH) Inhibitors Segment by Application
2.3.1 Hospital
2.3.2 Research Center
2.3.3 Other
2.3.4 Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application
2.3.4.1 Isocitrate Dehydrogenase (IDH) Inhibitors Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Application (2021-2026)
3 ISOCITRATE DEHYDROGENASE (IDH) INHIBITORS MARKET SIZE BY PLAYER
3.1 Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Player
3.1.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue by Player (2021-2026)
3.1.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Player (2021-2026)
3.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ISOCITRATE DEHYDROGENASE (IDH) INHIBITORS BY REGION
4.1 Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (2021-2026)
4.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Annual Revenue by Country/Region (2021-2026)
4.3 Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth (2021-2026)
4.4 APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth (2021-2026)
4.5 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth (2021-2026)
4.6 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021-2026)
5.2 Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026)
5.3 Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (2021-2026)
6.2 APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026)
6.3 APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021-2026)
7.2 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026)
7.3 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors by Region (2021-2026)
8.2 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026)
8.3 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ISOCITRATE DEHYDROGENASE (IDH) INHIBITORS MARKET FORECAST
10.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Region (2027-2032)
10.1.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Region (2027-2032)
10.1.2 Americas Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.1.3 APAC Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.1.4 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.1.5 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.2 Americas Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Country (2027-2032)
10.2.1 United States Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.2.2 Canada Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.2.3 Mexico Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.2.4 Brazil Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.3 APAC Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Region (2027-2032)
10.3.1 China Isocitrate Dehydrogenase (IDH) Inhibitors Market Forecast
10.3.2 Japan Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.3.3 Korea Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.3.4 Southeast Asia Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.3.5 India Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.3.6 Australia Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.4 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Country (2027-2032)
10.4.1 Germany Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.4.2 France Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.4.3 UK Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.4.4 Italy Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.4.5 Russia Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.5 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Region (2027-2032)
10.5.1 Egypt Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.5.2 South Africa Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.5.3 Israel Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.5.4 Turkey Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
10.6 Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Type (2027-2032)
10.7 Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Isocitrate Dehydrogenase (IDH) Inhibitors Forecast
11 KEY PLAYERS ANALYSIS
11.1 Agios Pharmaceuticals
11.1.1 Agios Pharmaceuticals Company Information
11.1.2 Agios Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
11.1.3 Agios Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Agios Pharmaceuticals Main Business Overview
11.1.5 Agios Pharmaceuticals Latest Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Information
11.2.2 Bristol-Myers Squibb Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
11.2.3 Bristol-Myers Squibb Isocitrate Dehydrogenase (IDH) Inhibitors Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bristol-Myers Squibb Main Business Overview
11.2.5 Bristol-Myers Squibb Latest Developments
11.3 Idenix Pharmaceuticals
11.3.1 Idenix Pharmaceuticals Company Information
11.3.2 Idenix Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
11.3.3 Idenix Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Idenix Pharmaceuticals Main Business Overview
11.3.5 Idenix Pharmaceuticals Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
11.4.3 Novartis Isocitrate Dehydrogenase (IDH) Inhibitors Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Bayer AG
11.5.1 Bayer AG Company Information
11.5.2 Bayer AG Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
11.5.3 Bayer AG Isocitrate Dehydrogenase (IDH) Inhibitors Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Bayer AG Main Business Overview
11.5.5 Bayer AG Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Isocitrate Dehydrogenase (IDH) Inhibitors Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Isocitrate Dehydrogenase (IDH) Inhibitors Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Inhibitors
Table 4. Major Players of Intravenous Inhibitors
Table 5. Isocitrate Dehydrogenase (IDH) Inhibitors Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Type (2021-2026)
Table 8. Isocitrate Dehydrogenase (IDH) Inhibitors Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Application (2021-2026)
Table 11. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Player (2021-2026)
Table 13. Isocitrate Dehydrogenase (IDH) Inhibitors Key Players Head office and Products Offered
Table 14. Isocitrate Dehydrogenase (IDH) Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Region (2021-2026)
Table 19. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Country (2021-2026)
Table 23. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Type (2021-2026)
Table 25. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Application (2021-2026)
Table 27. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Region (2021-2026)
Table 29. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Country (2021-2026)
Table 33. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Isocitrate Dehydrogenase (IDH) Inhibitors
Table 39. Key Market Challenges & Risks of Isocitrate Dehydrogenase (IDH) Inhibitors
Table 40. Key Industry Trends of Isocitrate Dehydrogenase (IDH) Inhibitors
Table 41. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Agios Pharmaceuticals Details, Company Type, Isocitrate Dehydrogenase (IDH) Inhibitors Area Served and Its Competitors
Table 46. Agios Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
Table 47. Agios Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Agios Pharmaceuticals Main Business
Table 49. Agios Pharmaceuticals Latest Developments
Table 50. Bristol-Myers Squibb Details, Company Type, Isocitrate Dehydrogenase (IDH) Inhibitors Area Served and Its Competitors
Table 51. Bristol-Myers Squibb Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
Table 52. Bristol-Myers Squibb Isocitrate Dehydrogenase (IDH) Inhibitors Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Bristol-Myers Squibb Main Business
Table 54. Bristol-Myers Squibb Latest Developments
Table 55. Idenix Pharmaceuticals Details, Company Type, Isocitrate Dehydrogenase (IDH) Inhibitors Area Served and Its Competitors
Table 56. Idenix Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
Table 57. Idenix Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Idenix Pharmaceuticals Main Business
Table 59. Idenix Pharmaceuticals Latest Developments
Table 60. Novartis Details, Company Type, Isocitrate Dehydrogenase (IDH) Inhibitors Area Served and Its Competitors
Table 61. Novartis Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
Table 62. Novartis Isocitrate Dehydrogenase (IDH) Inhibitors Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Novartis Main Business
Table 64. Novartis Latest Developments
Table 65. Bayer AG Details, Company Type, Isocitrate Dehydrogenase (IDH) Inhibitors Area Served and Its Competitors
Table 66. Bayer AG Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
Table 67. Bayer AG Isocitrate Dehydrogenase (IDH) Inhibitors Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Bayer AG Main Business
Table 69. Bayer AG Latest Developments
Table 1. Isocitrate Dehydrogenase (IDH) Inhibitors Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Isocitrate Dehydrogenase (IDH) Inhibitors Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Inhibitors
Table 4. Major Players of Intravenous Inhibitors
Table 5. Isocitrate Dehydrogenase (IDH) Inhibitors Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Type (2021-2026)
Table 8. Isocitrate Dehydrogenase (IDH) Inhibitors Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Application (2021-2026)
Table 11. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Player (2021-2026)
Table 13. Isocitrate Dehydrogenase (IDH) Inhibitors Key Players Head office and Products Offered
Table 14. Isocitrate Dehydrogenase (IDH) Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Region (2021-2026)
Table 19. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Country (2021-2026)
Table 23. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Type (2021-2026)
Table 25. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Application (2021-2026)
Table 27. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Region (2021-2026)
Table 29. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Country (2021-2026)
Table 33. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Isocitrate Dehydrogenase (IDH) Inhibitors
Table 39. Key Market Challenges & Risks of Isocitrate Dehydrogenase (IDH) Inhibitors
Table 40. Key Industry Trends of Isocitrate Dehydrogenase (IDH) Inhibitors
Table 41. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Agios Pharmaceuticals Details, Company Type, Isocitrate Dehydrogenase (IDH) Inhibitors Area Served and Its Competitors
Table 46. Agios Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
Table 47. Agios Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Agios Pharmaceuticals Main Business
Table 49. Agios Pharmaceuticals Latest Developments
Table 50. Bristol-Myers Squibb Details, Company Type, Isocitrate Dehydrogenase (IDH) Inhibitors Area Served and Its Competitors
Table 51. Bristol-Myers Squibb Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
Table 52. Bristol-Myers Squibb Isocitrate Dehydrogenase (IDH) Inhibitors Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Bristol-Myers Squibb Main Business
Table 54. Bristol-Myers Squibb Latest Developments
Table 55. Idenix Pharmaceuticals Details, Company Type, Isocitrate Dehydrogenase (IDH) Inhibitors Area Served and Its Competitors
Table 56. Idenix Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
Table 57. Idenix Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Idenix Pharmaceuticals Main Business
Table 59. Idenix Pharmaceuticals Latest Developments
Table 60. Novartis Details, Company Type, Isocitrate Dehydrogenase (IDH) Inhibitors Area Served and Its Competitors
Table 61. Novartis Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
Table 62. Novartis Isocitrate Dehydrogenase (IDH) Inhibitors Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Novartis Main Business
Table 64. Novartis Latest Developments
Table 65. Bayer AG Details, Company Type, Isocitrate Dehydrogenase (IDH) Inhibitors Area Served and Its Competitors
Table 66. Bayer AG Isocitrate Dehydrogenase (IDH) Inhibitors Product Offered
Table 67. Bayer AG Isocitrate Dehydrogenase (IDH) Inhibitors Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Bayer AG Main Business
Table 69. Bayer AG Latest Developments
LIST OF FIGURES
Figure 1. Isocitrate Dehydrogenase (IDH) Inhibitors Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Isocitrate Dehydrogenase (IDH) Inhibitors Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Isocitrate Dehydrogenase (IDH) Inhibitors Sales Market Share by Country/Region (2025)
Figure 8. Isocitrate Dehydrogenase (IDH) Inhibitors Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Type in 2025
Figure 10. Isocitrate Dehydrogenase (IDH) Inhibitors in Hospital
Figure 11. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market: Hospital (2021-2026) & ($ millions)
Figure 12. Isocitrate Dehydrogenase (IDH) Inhibitors in Research Center
Figure 13. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market: Research Center (2021-2026) & ($ millions)
Figure 14. Isocitrate Dehydrogenase (IDH) Inhibitors in Other
Figure 15. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market: Other (2021-2026) & ($ millions)
Figure 16. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Application in 2025
Figure 17. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Player in 2025
Figure 18. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Region (2021-2026)
Figure 19. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2021-2026 ($ millions)
Figure 20. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2021-2026 ($ millions)
Figure 21. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2021-2026 ($ millions)
Figure 23. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Value Market Share by Country in 2025
Figure 24. United States Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Region in 2025
Figure 29. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Type (2021-2026)
Figure 30. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Application (2021-2026)
Figure 31. China Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 35. India Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Country in 2025
Figure 38. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Type (2021-2026)
Figure 39. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Application (2021-2026)
Figure 40. Germany Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 41. France Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 54. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 55. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 57. United States Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 58. Canada Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 59. Mexico Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 60. Brazil Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 61. China Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 62. Japan Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 63. Korea Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 65. India Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 66. Australia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 67. Germany Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 68. France Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 69. UK Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 70. Italy Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 71. Russia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 72. Egypt Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 73. South Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 74. Israel Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 75. Turkey Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 76. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 1. Isocitrate Dehydrogenase (IDH) Inhibitors Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Isocitrate Dehydrogenase (IDH) Inhibitors Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Isocitrate Dehydrogenase (IDH) Inhibitors Sales Market Share by Country/Region (2025)
Figure 8. Isocitrate Dehydrogenase (IDH) Inhibitors Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Type in 2025
Figure 10. Isocitrate Dehydrogenase (IDH) Inhibitors in Hospital
Figure 11. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market: Hospital (2021-2026) & ($ millions)
Figure 12. Isocitrate Dehydrogenase (IDH) Inhibitors in Research Center
Figure 13. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market: Research Center (2021-2026) & ($ millions)
Figure 14. Isocitrate Dehydrogenase (IDH) Inhibitors in Other
Figure 15. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market: Other (2021-2026) & ($ millions)
Figure 16. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Application in 2025
Figure 17. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Player in 2025
Figure 18. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Region (2021-2026)
Figure 19. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2021-2026 ($ millions)
Figure 20. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2021-2026 ($ millions)
Figure 21. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2021-2026 ($ millions)
Figure 23. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Value Market Share by Country in 2025
Figure 24. United States Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Region in 2025
Figure 29. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Type (2021-2026)
Figure 30. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Application (2021-2026)
Figure 31. China Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 35. India Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Country in 2025
Figure 38. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Type (2021-2026)
Figure 39. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Application (2021-2026)
Figure 40. Germany Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 41. France Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 54. APAC Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 55. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 57. United States Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 58. Canada Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 59. Mexico Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 60. Brazil Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 61. China Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 62. Japan Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 63. Korea Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 65. India Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 66. Australia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 67. Germany Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 68. France Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 69. UK Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 70. Italy Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 71. Russia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 72. Egypt Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 73. South Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 74. Israel Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 75. Turkey Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
Figure 76. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Isocitrate Dehydrogenase (IDH) Inhibitors Market Size 2027-2032 ($ millions)
